Welcome to
Gilead Medical Information

This site is an online medical resource that provides access to scientific information about Gilead products and related information. The information provided is not intended to be and should not be understood to provide medical advice.

Choose an option that describes you:

By clicking “I’m a US healthcare professional”, you’re acknowledging that you’re a healthcare professional practicing in the US. This site is an educational resource for US healthcare professionals and may include products or uses that have not been approved by the US Food and Drug Administration.

ELCC 2025

ELCC 2025
March 26-29, 2025
Paris, France

European Lung Cancer Congress 20245.

Explore more information for Gilead Oncology therapies

Material Type

Poster

Filter by Keyword(s)

Results (1)

Brain metastases and actionable genetic alterations with sacituzumab govitecan versus docetaxel in metastatic non-small cell lung cancer: subgroups of the phase III EVOKE-01 trial

Author(s): Felip, E

trodelvy
Oncology
NSCLC
Sacituzumab

View Poster

Welcome to Gilead Medical Information

Choose an option that describes you:

ELCC 2025

Filter results with keywords such as:

Brain metastases and actionable genetic alterations with sacituzumab govitecan versus docetaxel in metastatic non-small cell lung cancer: subgroups of the phase III EVOKE-01 trial

Chat

Medical Inquiry

Meeting Request

You are leaving this website

Welcome to
Gilead Medical Information